OpenAI is facing lawsuits from seemingly every direction, posing major risks for Sam Altman and ChatGPT. Here are the top ...

As investors start to take sides in the AI race, Sam Altman’s buddies are getting burned.

Over the weekend, Altman spoke more about OpenAI's AI device in an interview at Emerson Collective’s 9th annual Demo Day in ...

The OpenAI CEO and former Apple designer say that the mysterious device could be released in as soon as two years.

OpenAI CEO Sam Altman and io Products creator Jony Ive forged a friendship that led to OpenAI's acquisition of io, and ...

At Emerson Collective’s Demo Day, Laurene Powell Jobs got Jony Ive and Sam Altman to open up a bit more about what they’re building together. In the interview, the duo reveal that they have their ...

OpenAI CEO Sam Altman recently said that the company is doing “well more” than $13 billion in annual revenue — and he sounded a little testy when pressed on how it will pay for its massive spending ...

OpenAI CEO Sam Altman issued a major update for the AI video app Sora in the aftermath of copyright concerns from Hollywood. The tech power player released a new statement Friday evening, where he ...

OpenAI CEO Sam Altman said that he tried semaglutide "before it was cool" — and that it sent him to the hospital. Semaglutide is sold under brand names like Ozempic and Wegovy. Elon Musk has also said ...

Has Sam Altman spent too much time talking with ChatGPT lately, or has he finally taken a break from his delusion-inducing chatbot and smelled the roses? We ask because the man responsible for ...